Clinical Study Aviation, space, and environmental medicine 1976

Screening test for decompression sickness.

Hart GB — Aviation, space, and environmental medicine, 1976

View Original on PubMed PMID 971182

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers investigated the utility of fibrin-fibrinogen degradation products (FDP) tests in 18 patients with a history of diving-related illness.

What They Found

Among 18 patients, 8 with serious neurological signs had positive FDP tests and required repetitive hyperbaric oxygen therapy. In contrast, 6 patients with local musculoskeletal complaints had negative FDP tests and were asymptomatic after one treatment. The FDP test appears useful for identifying severe decompression sickness.

Canadian Relevance

This study has no direct Canadian connection.

Study Limitations

A significant limitation of this study is its very small sample size of only 18 patients.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type	Clinical Study
Category	Neurological
Source	Pubmed
PubMed ID	971182
Year Published	1976
Journal	Aviation, space, and environmental medicine
MeSH Terms	Adolescent; Adult; Decompression Sickness; Disseminated Intravascular Coagulation; Diving; Fibrin Fibrinogen Degradation Products; Humans; Hyperbaric Oxygenation; Male; Middle Aged

Related Research

PLoS ONE | 2013 RCT

Hyperbaric oxygen induces late neuroplasticity in post stroke patients--randomized, prospective trial.

Efrati S, Fishlev G, Bechor Y, et al.

J Neurotrauma | 2018 Systematic Review

Hyperbaric oxygen therapy in the treatment of acute severe traumatic brain injury: a systematic review

Daly S, Thorpe M, Rockswold S, et al.

J Neurotrauma | 2012 Pilot Study

A phase I study of low-pressure hyperbaric oxygen therapy for blast-induced post-concussion syndrome and PTSD

Harch PG, Andrews SR, Fogarty EF, et al.

Scientific Reports | 2022 RCT

Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial.

Hadanny A, Zilberman-Itskovich S, Catalogna M, et al.

PLoS ONE | 2013 RCT

Hyperbaric oxygen therapy can improve post concussion syndrome years after mild traumatic brain injury — randomized prospective trial

Boussi-Gross R, Golan H, Fishlev G, et al.

See all Neurological research

View on PubMed Back to Research Library

Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 2, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology